Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Jason R Ruth"'
Autor:
Jason R. Ruth, Dhruv K. Pant, Tien-chi Pan, Hans E. Seidel, Sanjeethan C. Baksh, Blaine A. Keister, Rita Singh, Christopher J. Sterner, Suzanne J. Bakewell, Susan E. Moody, George K. Belka, Lewis A. Chodosh
Publikováno v:
Breast Cancer Research, Vol 23, Iss 1, Pp 1-23 (2021)
Abstract Background Breast cancer mortality is principally due to tumor recurrence, which can occur following extended periods of clinical remission that may last decades. While clinical latency has been postulated to reflect the ability of residual
Externí odkaz:
https://doaj.org/article/6df180a2332146bc930a618f952a3805
Autor:
Christopher S Nabel, Stephen Sameroff, Dustin Shilling, Daisy Alapat, Jason R Ruth, Mitsuhiro Kawano, Yasuharu Sato, Katie Stone, Signe Spetalen, Federico Valdivieso, Michael D Feldman, Amy Chadburn, Alexander Fosså, Frits van Rhee, W Ian Lipkin, David C Fajgenbaum
Publikováno v:
PLoS ONE, Vol 14, Iss 6, p e0218660 (2019)
Castleman disease (CD) describes a spectrum of heterogeneous disorders defined by characteristic lymph node histopathology. Enlarged lymph nodes demonstrating CD histopathology can occur in isolation (unicentric CD; UCD) sometimes accompanied by mild
Externí odkaz:
https://doaj.org/article/59ac6066c6b0466b9662fc96a41cec1d
Autor:
Lewis A. Chodosh, Jason R. Ruth, James V. Alvarez, Kristi R. Chakrabarti, Dhruv K. Pant, Tien-Chi Pan, Yi Feng
PDF file 645K, This file contains supplemental figures that provided supportive evidence to the main conclusion described in the manuscript
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3be234b4705a0e95b5ea63d84ecef1e5
https://doi.org/10.1158/2159-8290.22530752.v1
https://doi.org/10.1158/2159-8290.22530752.v1
Autor:
Lewis A. Chodosh, Jason R. Ruth, James V. Alvarez, Kristi R. Chakrabarti, Dhruv K. Pant, Tien-Chi Pan, Yi Feng
PDF file 70K, This file contains detailed information about the experimental procedures and the reagents used in the assays described in the manuscript
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60cec2c4e129f7268b9fd9b2370796bb
https://doi.org/10.1158/2159-8290.22530749.v1
https://doi.org/10.1158/2159-8290.22530749.v1
Autor:
Lewis A. Chodosh, Jason R. Ruth, James V. Alvarez, Kristi R. Chakrabarti, Dhruv K. Pant, Tien-Chi Pan, Yi Feng
PDF file 49K, This file contains text descriptions for each corresponding supplemental figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b51e7521c76029a7d2b1ea7bc57af56
https://doi.org/10.1158/2159-8290.22530755.v1
https://doi.org/10.1158/2159-8290.22530755.v1
Autor:
Amrit Singh, Anthony P. Schwarer, Helen L. Partridge, Frits van Rhee, Daniel J. Arenas, David C. Fajgenbaum, Katie L. Stone, Mariko Okumura, Jason R. Ruth, Nelson Hamerschlak, Michael R. Betts, Thomas S. Uldrick, Gerald Wertheim, Christopher S. Nabel, Taku Kambayashi, Michael B. Jordan, Sheila K Pierson, Fabio Freire José, Alberto Sada Japp, Arthur H. Rubenstein, Adam D. Cohen, Ruth-Anne Langan, Vera P. Krymskaya
Publikováno v:
Journal of Clinical Investigation. 129:4451-4463
BACKGROUND Idiopathic multicentric Castleman disease (iMCD) is a hematologic illness involving cytokine-induced lymphoproliferation, systemic inflammation, cytopenias, and life-threatening multi-organ dysfunction. The molecular underpinnings of inter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8033ac4d600fd62a1b2cfd366a713000
https://doi.org/10.1172/jci126091
https://doi.org/10.1172/jci126091
Autor:
Suzanne J. Bakewell, Susan E. Moody, Christopher J. Sterner, Rita Singh, Hans E. Seidel, Sanjeethan C. Baksh, Tien-chi Pan, Jason R. Ruth, George K. Belka, Dhruv K. Pant, Lewis A. Chodosh, Blaine A. Keister
Publikováno v:
Breast Cancer Research : BCR
Breast Cancer Research, Vol 23, Iss 1, Pp 1-23 (2021)
Breast Cancer Research, Vol 23, Iss 1, Pp 1-23 (2021)
Background Breast cancer mortality is principally due to tumor recurrence, which can occur following extended periods of clinical remission that may last decades. While clinical latency has been postulated to reflect the ability of residual tumor cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53d531fba9b2ef635effeedb90eaec33
http://europepmc.org/articles/PMC8178846
http://europepmc.org/articles/PMC8178846
Autor:
Manjula Reddy, Sheila K Pierson, Craig Tendler, Alessia Dalla Pria, Alexander Fosså, Philip Beineke, Nancy A. Shadick, Mark Bower, Sushila A. Shenoy, Christopher S. Nabel, Alexander M. Gorzewski, Michael E. Weinblatt, Sophia A. T. Parente, Jason R. Ruth, Mary Guilfoyle, Laura M. Katz, Ana B Oromendia, Daniel J. Arenas, Taku Kambayashi, David M. Lee, Ruth-Anne Langan Pai, David C. Fajgenbaum, Frits van Rhee, Yasufumi Masaki, Jason G. Mezey
Publikováno v:
Blood Adv
Idiopathic multicentric Castleman disease (iMCD) is a poorly understood hematologic disorder involving cytokine-induced polyclonal lymphoproliferation, systemic inflammation, and potentially fatal multiorgan failure. Although the etiology of iMCD is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bca99d86eae5f7a039e24dd4a68fab32
http://hdl.handle.net/10852/92185
http://hdl.handle.net/10852/92185
Autor:
Megan S. Lim, Mileva Repasky, Simone Ferrero, Katherine Floess, Jose Luis Patier, Gordan Srkalovic, Johnson S. Khor, Sheila K Pierson, Thomas S. Uldrick, Eric Haljasmaa, Alexander M. Gorzewski, Erin NaPier, Matthew Streetly, Christian Hoffmann, Amy Y. Liu, Bette Jacobs, Faizaan Akhter, Jason R. Ruth, Alexander Fosså, Amy Chadburn, Linus Angenendt, Eric Oksenhendler, Victoria Powers, Corey Casper, Jasira Ziglar, Arthur H. Rubenstein, Kojo S.J. Elenitoba-Johnson, Frits van Rhee, Louis Terriou, Elaine S. Jaffe, Pier Luigi Zinzani, David C. Fajgenbaum, Mark Avery Tamakloe, Raj Jayanthan
Publikováno v:
Cell Reports Medicine
Summary Geographically dispersed patients, inconsistent treatment tracking, and limited infrastructure slow research for many orphan diseases. We assess the feasibility of a patient-powered study design to overcome these challenges for Castleman dise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b375916c8e02a5d333d95ff8a42c30ca
http://europepmc.org/articles/PMC7762771
http://europepmc.org/articles/PMC7762771
Autor:
Amy Chadburn, Dale Frank, Michele Paessler, Mary Jo Lechowicz, Gordan Srkalovic, Sheila K Pierson, Makoto Ide, Gisele W. B. Colleoni, Adam Bagg, Ahmet Dogan, Thomas S. Uldrick, Raymond S.M. Wong, Razelle Kurzrock, Peter M. Voorhees, Frits van Rhee, Elaine S. Jaffe, Michael P. Croglio, Alexander Suarez, Megan S. Lim, Vera P. Krymskaya, Raj Jayanthan, Sunita D. Nasta, David C. Fajgenbaum, David Simpson, Angela Dispenzieri, Corey Casper, David Wu, David M. Menke, Shanmuganathan Chandrakasan, Eric Oksenhendler, Alexander Fosså, Jean François Rossi, Amy Y. Liu, Jason R. Ruth, Kazuyuki Yoshizaki, Kojo S.J. Elenitoba-Johnson, Dermot Kelleher, Christopher S. Nabel
Publikováno v:
Blood. 129:1646-1657
Human herpesvirus-8 (HHV-8)-negative, idiopathic multicentric Castleman disease (iMCD) is a rare and life-threatening disorder involving systemic inflammatory symptoms, polyclonal lymphoproliferation, cytopenias, and multiple organ system dysfunction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a99366fa7f9052f86a4071d4565eef1
https://doi.org/10.1182/blood-2016-10-746933
https://doi.org/10.1182/blood-2016-10-746933